MP-1115

N/A

Report date: 2025/06/11 11:08:35
NME

Base Information

Drug NameMP-1115
Drug Alias NameMP-1000 (Machavert Pharmaceuticals)phospholipid composition (Machavert Pharmaceuticals)MP-1075MP-1115MP-1081 +[6] 
ClassificationSmall molecules > Lipid
Mechanisms of ActionAnticancer protein kinase inhibitorsImmunomodulatorsCyclin-dependent kinase 8 inhibitors
TargetsCyclin-dependent kinase 8
Therapy Area/IndicationsSolid tumoursAutoimmune DiseasesHematologic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMachavert Pharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesMachavert Pharmaceuticals LLC
Inactive CompaniesN/A
Active IndicationsSolid tumoursAutoimmune DiseasesHematologic Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A